Scott E. Klewer

Scott E. Klewer

Auto-generated profile, based on publicly available information

Scott E. Klewer

Department of Pediatrics (M.D.S., J.G.A., S.E.K.), University of Arizona College of Medicine, Tucson

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2023 in Circulation
Verified
Journal Article
Closed access
KDKarrie F. Downing
Karrie F. Downing
WNWendy N. Nembhard
Wendy N. Nembhard
CRCharles E. Rose
Charles E. Rose
JAJennifer G. Andrews
Jennifer G. Andrews
AGAnthony Goudie
Anthony Goudie
SFSherry L. Farr
Sherry L. Farr
BACKGROUND: Limited population-based information is available on long-term survival of US individuals with congenital heart defects (CHDs). Therefore, we assessed patterns in survival from birth until young adulthood (ie, 35 years of age) and associated factors among a population-based sample of US individuals with CHDs. METHODS: Individuals born between 1980 and 1997 with CHDs identified in 3 US birth defect surveillance systems were linked to death records through 2015 to identify those deceased and the year of their death. Kaplan-Meier survival curves, adjusted risk ratios (aRRs) for infant mortality (ie, death during the first year of life), and Cox proportional hazard ratios for survival after the first year of life (aHRs) were used to estimate the probability of survival and associated factors. Standardized mortality ratios compared infant mortality, >1-year mortality, >10-year mortality, and >20-year mortality among individuals with CHDs with general population estimates. RESULTS: Among 11 695 individuals with CHDs, the probability of survival to 35 years of age was 81.4% overall, 86.5% among those without co-occurring noncardiac anomalies, and 92.8% among those who survived the first year of life. Characteristics associated with both infant mortality and reduced survival after the first year of life, respectively, included severe CHDs (aRR=4.08; aHR=3.18), genetic syndromes (aRR=1.83; aHR=3.06) or other noncardiac anomalies (aRR=1.54; aHR=2.53), low birth weight (aRR=1.70; aHR=1.29), and Hispanic (aRR=1.27; aHR=1.42) or non-Hispanic Black (aRR=1.43; aHR=1.80) maternal race and ethnicity. Individuals with CHDs had higher infant mortality (standardized mortality ratio=10.17), >1-year mortality (standardized mortality ratio=3.29), and >10-year and >20-year mortality (both standardized mortality ratios ≈1.5) than the general population; however, after excluding those with noncardiac anomalies, >1-year mortality for those with nonsevere CHDs and >10-year and >20-year mortality for those with any CHD were similar to the general population. CONCLUSIONS: Eight in 10 individuals with CHDs born between1980 and 1997 survived to 35 years of age, with disparities by CHD severity, noncardiac anomalies, birth weight, and maternal race and ethnicity. Among individuals without noncardiac anomalies, those with nonsevere CHDs experienced similar mortality between 1 and 35 years of age as in the general population, and those with any CHD experienced similar mortality between 10 and 35 years of age as in the general population.

2 November 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
KDKarrie F. Downing
Karrie F. Downing
MOMatthew E. Oster
Matthew E. Oster
SKScott E. Klewer
Scott E. Klewer
CRCharles E. Rose
Charles E. Rose
WNWendy N. Nembhard
Wendy N. Nembhard
SFSherry L. Farr
Sherry L. Farr
Background: Disabilities have implications for health, well‐being, and health care, yet limited information is available on the percentage of adults with congenital heart defects (CHD) living with disabilities. We evaluated the prevalence of disability and associated characteristics among the 2016–2019 CH STRONG (Congenital Heart Survey to Recognize Outcomes, Needs, and Well‐Being) population‐based sample of 19‐ to 38‐year‐olds with CHD from 3 US locations. Methods and Results: Prevalence of disability types (hearing, vision, cognition, mobility, self‐care, living independently) were compared with similarly aged adults from the general population as estimated by the American Community Survey and standardized to the CH STRONG eligible population to reduce nonresponse bias and confounding. Health‐related quality of life (HRQOL) was measured via Patient‐Reported Outcomes Measurement Information System Global Health Scale T‐scores standardized to US 18‐ to 34‐year‐olds. Separate multivariable regression models assessed associations between disability and HRQOL. Of 1478 participants, 40% reported disabilities, with cognition most prevalent (29%). Of those reporting disability, 45% ever received disability benefits and 46% were unemployed. Prevalence of disability types were 5 to 8 times higher in adults with CHD than the general population. Those with ≥1 disability had greater odds of being female, and of having non‐Hispanic Black maternal race and ethnicity, severe CHD, recent cardiac care, and noncardiac congenital anomalies. On average, adults with CHD and cognition, mobility, and self‐care disabilities had impaired mental HRQOL and those with any disability type had impaired physical HRQOL. Conclusions: Two of 5 adults with CHD may have disabilities, which are associated with impaired HRQOL. These results may inform healthcare needs and services for this growing population.

16 April 2002 in American Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
IJIan N. Jongewaard
Ian N. Jongewaard
RLRonald M. Lauer
Ronald M. Lauer
DBDouglas A. Behrendt
Douglas A. Behrendt
SPShivanand Patil
Shivanand Patil
SKScott E. Klewer
Scott E. Klewer

1 June 2006 in Gene Expression Patterns
Verified
Journal Article
Closed access
SKScott E Klewer
Scott E Klewer
TYTatiana Yatskievych
Tatiana Yatskievych
KPKristen Pogreba
Kristen Pogreba
MSMark V Stevens
Mark V Stevens
PAParker B Antin
Parker B Antin
TCTodd D Camenisch
Todd D Camenisch

1 December 2012 in Telemedicine and e-Health
Verified
Journal Article
Closed access
JHJessica Haley
Jessica Haley
SKScott E. Klewer
Scott E. Klewer
BBBrent J. Barber
Brent J. Barber
FMF. John Meaney
F. John Meaney
RDRichard L. Donnerstein
Richard L. Donnerstein
DLDaniela Lax
Daniela Lax
Objective: We report our experience with tele-echocardiography and echocardiograms recorded digitally or on videotape (recorded-echos) at The University of Arizona from August 2006 to December 2010 and compare their quality and diagnostic accuracy. Materials and Methods: Tele-echocardiograms (tele-echos) were transmitted from the Yuma Regional Medical Center to The University of Arizona via a T-1 and aT-3 line at a bandwidth of 768 kilobits per second. Recorded-echos were shipped for interpretation to The University of Arizona by overnight mail. Diagnostic accuracy was assessed by comparing tele- and recorded-echos with electrocardiograms performed by a pediatric cardiologist (PedsCard-echos). Results: Three hundred forty-six tele-echos in 260 patients and 455 recorded-echos in 406 patients were performed (median age, 6 and 8 days, respectively). Indications included possible congenital heart disease (CHD), patent ductus arteriosus (PDA), and persistent pulmonary hypertension of the newborn. Diagnostic categories included complex CHD, non-critical disease, PDA, and other. PedsCard-echos were available for 27% of the tele-echo and 30% of the recorded-echo patients. Comparisons between tele- and PedsCard-echo yielded no discrepancies in 12 (23%), expected resolution of condition in 26 (49%), and minor in 14 (26%). One (2%) major discrepancy was detected. Comparisons between recorded- and PedsCard-echo showed no discrepancies in 28 (40%), expected resolution of condition in 14 (20%), and minor discrepancies in 28 (40%) patients. No significant difference with respect to discrepancies was detected between tele- and recorded-echos. There was significant ( p <0.01) improvement in tele- and recorded-echo study quality by 2010. Conclusions: (1) Tele-echocardiography can be performed successfully with excellent accuracy. (2) The quality of tele- and recorded-echo studies improved toward the end of the analysis period. (3) Although initially tele-echo studies were more accurate than recorded-echo studies, there was no difference between these two types of studies by the fourth year of the study. (4) Both tele- and recorded-echos were indispensible in the remote diagnosis of CHD.

1 June 2021 in The American Journal of Cardiology
Verified
Journal Article
Closed access
MSMichael D. Seckeler
Michael D. Seckeler
BBBrent J. Barber
Brent J. Barber
JCJamie N. Colombo
Jamie N. Colombo
ABAlyssa M. Bernardi
Alyssa M. Bernardi
AHAndrew W. Hoyer
Andrew W. Hoyer
SKScott E. Klewer
Scott E. Klewer